Overview

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Status:
Not yet recruiting

Trial end date:
2026-03-31

Target enrollment:

Participant gender:

Summary

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

Phase:

Phase 3

Details

Lead Sponsor:

The First Affiliated Hospital of University of Science and Technology of China

Treatments:

Tenecteplase